AKT1 and breast cancer: Identified mostly in basal-like/triple-negative BC, INPP4B is a novel tumor suppressor and inhibitor of PI3K/Akt signaling and cell survival in ER+ BC and, in one study, was linked to loss of PTEN in BC subtypes with poor prognosis [60].